Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 12/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 1.00 |
| ▸ | ADRA2A | P08913 | 4/20 | 1.00 |
| ▸ | SLC6A4 | P31645 | 4/20 | 1.00 |
| ▸ | OPRM1 | P35372 | 4/20 | 1.00 |
| ▸ | KCNH2 | Q12809 | 4/20 | 1.00 |
| ▸ | HPGD | P15428 | 3/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 3/20 | 1.00 |
| ▸ | TSHR | P16473 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 1.00 |
| ▸ | CHRM2 | P08172 | 1/20 | 1.00 |
| ▸ | SCN1A | P35498 | 4/20 | 0.81 |
| ▸ | SCN2A | Q99250 | 4/20 | 0.81 |
| ▸ | SCN3A | Q9NY46 | 4/20 | 0.81 |
| ▸ | SLC22A1 | O15245 | 3/20 | 0.74 |
| ▸ | ABCB11 | O95342 | 3/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydroquinine SCHEMBL109600 | 1.00 | CYP2D6 (1.00) | CYP2D6KDM4EALDH1A1HSD17B10ADRA2A | |
| Hydroquinidine SCHEMBL308963 | 1.00 | CYP2D6 (1.00) | CYP2D6KDM4EALDH1A1HSD17B10ADRA2A | |
| Hydroquinidine SCHEMBL22754573 | 1.00 | CYP2D6 (1.00) | CYP2D6KDM4EALDH1A1HSD17B10ADRA2A | |
| Hydroquinidine SCHEMBL25429627 | 1.00 | CYP2D6 (1.00) | CYP2D6KDM4EALDH1A1HSD17B10ADRA2A | |
| Hydroquinidine SCHEMBL109603 | 1.00 | CYP2D6 (1.00) | CYP2D6KDM4EALDH1A1HSD17B10ADRA2A | |
| Hydroquinidine SCHEMBL23509584 | 1.00 | CYP2D6 (1.00) | CYP2D6KDM4EALDH1A1HSD17B10ADRA2A | |
| Hydroquinidine SCHEMBL109602 | 1.00 | CYP2D6 (1.00) | CYP2D6KDM4EALDH1A1HSD17B10ADRA2A | |
| Hydroquinidine SCHEMBL25429352 | 1.00 | CYP2D6 (1.00) | CYP2D6KDM4EALDH1A1HSD17B10ADRA2A | |
| Hydroquinidine SCHEMBL22754576 | 1.00 | CYP2D6 (1.00) | CYP2D6KDM4EALDH1A1HSD17B10ADRA2A | |
| Hydroquinidine SCHEMBL308962 | 1.00 | CYP2D6 (1.00) | CYP2D6KDM4EALDH1A1HSD17B10ADRA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1350 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4745122-A1 | METHOD FOR PREPARING PYRROLE CARBOXYLATE COMPOUND | Sunshine Lake Pharma Co., Ltd. (CN) | 2026-05-20 | — | — | EP | claimed |
| EP-4531842-A2 | DOSAGE REGIMENS FOR TREATMENT OF DENGUE INFECTION | ATEA Pharmaceuticals, Inc. (US) | 2025-04-09 | — | — | EP | claimed |
| US-20250098680-A1 | A METHOD OF PLANT TREATMENT WITH QUINOLINE ALKALOIDS AND PESTICIDE COMPOSITIONS THEREOF | METABOLIC INSIGHTS LTD. (IL) | 2025-03-27 | — | — | US | claimed |
| EP-3694864-B1 | BORONIC ACID DERIVATIVES AND SYNTHESIS THEREOF | QPEX BIOPHARMA INC (US) | 2025-03-05 | — | — | EP | claimed |
| CN-119161280-B | Method for synthesizing chiral sulfoxide compound by allylation reaction | 南开大学 | 2025-01-24 | — | — | CN | claimed |
| WO-2025011627-A1 | METHOD FOR PREPARING PYRROLE CARBOXYLATE COMPOUND | 广东东阳光药业股份有限公司 | 2025-01-16 | — | — | WO | claimed |
| WO-2025011630-A1 | METHOD FOR PREPARING PYRROLE AMIDE COMPOUND AND INTERMEDIATE OF PYRROLE AMIDE COMPOUND | 广东东阳光药业股份有限公司 | 2025-01-16 | — | — | WO | claimed |
| WO-2025011628-A1 | METHOD FOR PREPARING PYRROLE AMIDE COMPOUND AND INTERMEDIATE THEREOF | 广东东阳光药业股份有限公司 | 2025-01-16 | — | — | WO | claimed |
| CN-119306645-A | Process for preparing pyrrole amide compounds and intermediates therefor | 广东东阳光药业股份有限公司 | 2025-01-14 | — | — | CN | claimed |
| CN-119306644-A | Process for preparing pyrrolecarboxylic acid compounds | 广东东阳光药业股份有限公司 | 2025-01-14 | — | — | CN | claimed |
| WO-1993007142-A1 | NEW LIGANDS FOR ASYMMETRIC DIHYDROXYLATION: MULTIPLE CINCHONA ALKALOID UNITS ATTACHED TO A CENTRAL HETEROCYCLIC CORE | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1993-04-15 | — | — | WO | claimed |
| EP-0526582-A1 | HETEROCYCLIC CHIRAL LIGANDS AND METHOD FOR CATALYTIC ASYMMETRIC DIHYDROXYLATION OF OLEFINS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1993-02-10 | — | — | EP | claimed |
| WO-1992020677-A1 | HETEROCYCLIC CHIRAL LIGANDS AND METHOD FOR CATALYTIC ASYMMETRIC DIHYDROXYLATION OF OLEFINS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1992-11-26 | — | — | WO | claimed |
| US-5126494-A | Complex osmium catalyst | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1992-06-30 | — | — | US | claimed |
| WO-1991016322-A2 | HETEROCYCLIC CHIRAL LIGANDS AND METHOD FOR CATALYTIC ASYMMETRIC DIHYDROXYLATION OF OLEFINS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1991-10-31 | — | — | WO | claimed |
| US-5006454-A | Containing pyrazoloazole magenta coupler, anti-color-fading agent, hydroquinone derivative | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1991-04-09 | — | — | US | claimed |
| EP-0395729-A1 | LIGAND-ACCELERATED CATALYTIC ASYMMETRIC DIHYDROXYLATION. | MASSACHUSETTS INST TECHNOLOGY (US) | 1990-11-07 | — | — | EP | claimed |
| US-4965364-A | OLEFIN, CHIRAL LIGAND, ORGANIC SOLVENT, WATER, AMINE OXIDE AND OSMIUM-CONTAINING COMPOUND | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1990-10-23 | — | — | US | claimed |
| WO-1989006225-A1 | LIGAND-ACCELERATED CATALYTIC ASYMMETRIC DIHYDROXYLATION | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1989-07-13 | — | — | WO | claimed |
| WO-1989005291-A1 | ENANTIOSELECTIVE PREPARATION OF SUBSTITUTED AMINOTHIOPHENOL DERIVATIVES | ICI AUSTRALIA OPERATIONS PROPRIETARY LIMITED (AU) | 1989-06-15 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250098680-A1 | A METHOD OF PLANT TREATMENT WITH QUINOLINE ALKALOIDS AND PESTICIDE COMPOSITIONS THEREOF | DDT, QDPR, KCNQ1 | CYP2D6 1333/4885KDM4E 1407/4885ALDH1A1 3159/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.